nicotine has been researched along with sodium acetate, anhydrous in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Areola, ED; Dangana, EO; Olaniyi, KS; Olatunji, LA; Omolekulo, TE; Soladoye, AO | 1 |
Adetunji, CO; Adeyanju, OA; Badmus, OO; Dibia, CL; Michael, OS; Oyewole, AL; Soetan, OA; Soladoye, AO | 1 |
3 other study(ies) available for nicotine and sodium acetate, anhydrous
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sodium acetate protects against nicotine-induced excess hepatic lipid in male rats by suppressing xanthine oxidase activity.
Topics: Animals; Area Under Curve; Fatty Acids, Nonesterified; Glucose Tolerance Test; Insulin Resistance; Lipid Peroxidation; Lipids; Liver; Male; Nicotine; Protective Agents; Rats; Rats, Wistar; ROC Curve; Sodium Acetate; Triglycerides; Xanthine Oxidase | 2020 |
Sodium acetate prevents nicotine-induced cardiorenal dysmetabolism through uric acid/creatine kinase-dependent pathway.
Topics: Animals; Creatine Kinase; Glucose; Glucose Tolerance Test; Heart; Insulin Resistance; Kidney; Male; Metabolic Networks and Pathways; Myocardium; Nicotine; Rats; Rats, Wistar; Sodium Acetate; Uric Acid | 2020 |